Company Reaches Major Inflection Point; Major Upside in Offing
On the heels of major news announcements and just ahead of key inflection points in its business model, we believe that is on the cusp of generating meaningful revenue later this quarter. In our view, this low-float digital media and technology company’s shares are set to return to the $3-4 level in the near term.
Read more...
 
Internet Gaming Pioneer’s Stock Set to Launch
With a first-mover advantage and a combination online gambling/online gaming approach, HKTU could potentially sign up millions of players following its 1H14 launch, and trade at a premium to the high-multiple online gaming group, which includes Zynga (NASDAQ – ZNGA). As HKTU achieves milestone events including the launch of specific games, player sign-ups and revenue from fees, we believe that the stock could reach the $2.00 level. We rate these shares Speculative Buy.
Read more...
 
Plandaí is Next to Ride the Marijuana Wave

As we have now entered 2014, the Company’s medical marijuana initiatives, announced in the fourth quarter of 2013, may take center stage now that the nation has overwhelmingly changed its stance toward broad and widespread cannabis acceptance.

Read more...
 
Nuvilex Making Great Strides in Medical Marijuana Initiatives

In the 21st century, certain initiatives have moved so far and so fast that they have tend to take on a life of their own. This is clearly the case with marijuana early 2014, now that the nation has overwhelmingly changed its stance toward broad and widespread use cannabis. Driven by its own steps in recent weeks, Nuvilex, Inc.’s (OTCQB – NVLX - $0.12 – Spec Buy) medical marijuana initiatives may take center stage for a spell, and rightfully so, given the shift in sentiment by consumers and investors alike.

Read more...
 
Industry Trends Favor ForeverGreen and Direct Marketing Firms

Given the favorable trends afforded the direct marketing space and the favorable valuations associated with stocks such as ForeverGreen, Nu Skin and Herbalife, consumers and investors alike could be rewarded.

Read more...
 
FVRG: Stock is a Triple on Huge EPS Growth Next Year
If FVRG meets its targets, the stock could nearly triple from current levels. Our target price of $3.00 reflects a reasonable 20x multiple on very achievable FY14E EPS of $0.15. Plus, if PowerStrips sales exceed management forecasts, upside to EPS exists. We rate these shares Speculative Buy.
Read more...
 
Stock Nears Year-High
Today we reiterate our Speculative Buy recommendation on SGD Holdings, which is up 40% on a huge increase in volume since our initiation last month. We believe that the rise is being driven by sales traction and the potential closing major retail distribution deals in the coming months.
Read more...
 
LifeApps To Take Advantage of Huge Mobile Health Growth

With the approach of the New Year comes the traditional New Year’s resolutions and desire to lose weight and become more fit. This seasonality, in addition to the “mHealth” industry growth should result in a surge in these shares heading into 2014.

Read more...
 
Record Diabetes Cases Highlight Need for Nuvilex Treatment

According to the latest estimates released recently by the International Diabetes Federation (IDF), the number of people diagnosed with diabetes worldwide is soaring. Moreover, with deaths occurring at a rate of 5.1 million annually, one person is dying of the disease every six seconds.

Read more...
 
VEND Can Double From Here

Although we do not formally cover Fresh Healthy Vending International, Inc. (OTCQB – VEND - $2.08 – Not Rated), we think the story is great and the stock has the legs to double from current levels, which is why we felt compelled to introduce the story today.

Read more...
 
<< Start < Prev 11 12 13 14 15 16 17 18 19 20 Next > End >>

Page 20 of 41